Christa Van Kan, our Strategic Director of Rare Diseases and Alex Artyomenko, Head of Rare Disease and RWE Research are looking forward to attending next week’s virtual Advanced Therapies Congress & Expo 2020.
They invite you to connect online to discuss how the Ergomed/PSR Orphan Experts team can best support your upcoming Advanced Therapy trials.
Christa and Alex can be reached here, or via their LinkedIn profiles:
- Christa Van Kan: Strategic Director Rare Diseases, Ergomed/PSR firstname.lastname@example.org
- Alex Artyomenko, Head of Rare Disease and RWE Research, Ergomed/PSR Alex.Artyomenko@ergomedplc.com